Heike Galbraith is a Partner at Dentons Global Advisors Interel and is based Brussels.
She specializes in partnering with companies and stakeholders to develop impactful strategies and advocate for meaningful solutions for the most critical health policy issues.
Ms. Galbraith has more than 20 years of experience in public affairs, stakeholder management, and advocacy across the healthcare and life sciences industry, specializing in several therapeutic areas, including vaccines, oncology, rare diseases, HIV/AIDS, and hepatitis.
She most recently served as Head of European Policy & Public Affairs at GCI Health. Previously, she was with Pfizer as Director of the Global Rare Disease and Vaccines Public Affairs team as well as the EU Government Affairs team, and was also Director of International Government Affairs at Gilead.
Ms. Galbraith worked in the European Parliament and as a consultant in two global communications firms. She holds a Master’s Degree in History, Politics and Public Law from the University of Heidelberg.